Dataset Information


Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.

ABSTRACT: The purpose of this study was to further define the biology of the 11q- neuroblastoma tumor subgroup by the integration of array-based comparative genomic hybridization with microRNA (miRNA) expression profiling data to determine if improved patient stratification is possible.A set of primary neuroblastoma (n = 160), which was broadly representative of all genetic subtypes, was analyzed by array-based comparative genomic hybridization and for the expression of 430 miRNAs. A 15-miRNA expression signature previously shown to be predictive of clinical outcome was used to analyze an independent cohort of 11q- tumors (n = 37).Loss of 4p and gain of 7q occurred at a significantly higher frequency in the 11q- tumors, further defining the genetic characteristics of this subtype. The 11q- tumors could be split into two subgroups using a miRNA expression survival signature that differed significantly in clinical outcome and the overall frequency of large-scale genomic imbalances, with the poor survival subgroup having significantly more imbalances. miRNAs from the expression signature, which were upregulated in unfavorable tumors, were predicted to target downregulated genes from a published mRNA expression classifier of clinical outcome at a higher-than-expected frequency, indicating the miRNAs might contribute to the regulation of genes within the signature.We show that two distinct biological subtypes of neuroblastoma with loss of 11q occur, which differ in their miRNA expression profiles, frequency of segmental imbalances, and clinical outcome. A miRNA expression signature, combined with an analysis of segmental imbalances, provides greater prediction of event-free survival and overall survival outcomes than 11q status by itself, improving patient stratification.


PROVIDER: S-EPMC2880207 | BioStudies | 2010-01-01

REPOSITORIES: biostudies

Similar Datasets

2009-01-01 | S-EPMC2773120 | BioStudies
2010-01-01 | S-EPMC4095771 | BioStudies
2011-01-01 | S-EPMC3229581 | BioStudies
2013-01-01 | S-EPMC3544899 | BioStudies
2013-01-01 | S-EPMC3477279 | BioStudies
2013-01-01 | S-EPMC3664071 | BioStudies
2015-01-01 | S-EPMC4491767 | BioStudies
2010-01-01 | S-EPMC2824410 | BioStudies
1000-01-01 | S-EPMC3241557 | BioStudies
2017-01-01 | S-EPMC5492892 | BioStudies